Multiple Sclerosis (MS) is the most common debilitating disease in young adults worldwide. Diagnosed in over 2.3 million people, this neuro-immunological disease is most prevalent in Europe and North America, with over 120,000 dia...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TIN2014-55710-R
HERRAMIENTAS DE NEUROIMAGEN PARA MEJORAR EL DIAGNOSIS Y EL S...
148K€
Cerrado
PID2020-114769RB-I00
MODELOS PARA LA ESCLEROSIS MULTIPLE USANDO DEEP LEARNING EN...
213K€
Cerrado
DPI2017-86696-R
MODELOS PREDICTIVOS PARA LA ESCLEROSIS MULTIPE USANDO BIOMAR...
218K€
Cerrado
PID2019-108435RB-I00
CUANTIFICACION Y CARACTERIZACION COMPUTACIONAL DE IMAGEN MUL...
214K€
Cerrado
PSI2016-78133-P
EVALUACION DEL DETERIORO ATENCIONAL EN LA ESCLEROSIS MULTIPL...
19K€
Cerrado
EBV-MS
Targeting Epstein Barr Virus Infection for Treatment and Pre...
8M€
Cerrado
Información proyecto MS Fatigue_Therapy
Duración del proyecto: 25 meses
Fecha Inicio: 2016-03-31
Fecha Fin: 2018-05-14
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Multiple Sclerosis (MS) is the most common debilitating disease in young adults worldwide. Diagnosed in over 2.3 million people, this neuro-immunological disease is most prevalent in Europe and North America, with over 120,000 diagnosed cases in Germany alone. Great strides have been made in developing medications that slow disease progression, however, the daily symptomatology of MS remains largely untreated. This research proposes investigations of (1) an instrument for objectively measuring MS fatigue and (2) a therapeutic methodology for MS fatigue and disability. Despite great individual variation in MS symptomatology, MS fatigue verges on characteristic, reported by 80% of patients. However, there is currently no standardized means of evaluating or treating MS fatigue. Movement Behavior Analysis and Scales Test (i.e., BAST) tests and pre- and post-test vital signs of 40 persons with MS will be compared to that of 40 neurotypical matched controls. If the BAST is shown to reliably measure MS fatigue, then a testing and rating system for large-scale clinical use will be developed. To test the ability of the BAST to measure changes in MS fatigue and categorize physical disability, a long-term controlled study of the impact of hippotherapy (i.e., therapeutic horseback riding) will be undertaken in 24 individuals with MS. The standardized BAST will afford a robust analysis of movement ability and disability, enabling measurement of symptoms including gait, balance, spasticity, and fatigue. To achieve project objectives while facilitating ample mentorship, this project brings together the movement research facilities and faculty of the German Sport University Cologne (including mentor Dr. Hedda Lausberg, creator of the BAST), researchers and hippotherapists at the Gold-Kraemer Foundation Center for Physical Activity and Sport, and an internship at the University of Cologne Department of Neurology and Center for Palliative Medicine.